FindTrial
Sign In

Hybrid coronary revascularization

PROCEDURE5 trials

Sponsors

Aarhus University Hospital Skejby, Shanghai Jiao Tong University School of Medicine, Seung-Jung Park, Tomsk National Research Medical Center of the Russian Academy of Sciences, Rigshospitalet, Denmark

Conditions

Coronary Artery Bypass GraftingCoronary Artery DiseaseCoronary Artery Disease ProgressionCoronary StenosisHeart Failure Due to Coronary Artery DiseasePercutaneous Coronary Revascularization

Unknown Phase

Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy
CompletedNCT02293928
Aarhus University Hospital SkejbyCoronary Artery Disease
Start: 2010-10-31End: 2013-04-30Updated: 2014-11-19
Optimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure
NCT02775578
Shanghai Jiao Tong University School of MedicineHeart Failure Due to Coronary Artery Disease
Start: 2016-04-30Target: 525Updated: 2016-05-18
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
TerminatedNCT03788369
Seung-Jung ParkCoronary Artery Bypass Grafting, Coronary Artery Disease Progression, Coronary Stenosis +1
Start: 2019-04-05End: 2026-04-13Updated: 2026-04-15
FUNctional eFficacy of Hybrid coronAry REvascularization
TerminatedNCT04698460
Tomsk National Research Medical Center of the Russian Academy of SciencesCoronary Artery Disease
Start: 2021-01-15End: 2023-05-05Updated: 2023-05-08
The HYCORE1 Trial: Hybrid Revascularization Versus Coronary Artery Bypass Grafting
Not yet recruitingNCT05504031
Rigshospitalet, DenmarkCoronary Artery Disease
Start: 2026-07-15End: 2044-01-01Target: 1048Updated: 2026-06-03

Related Papers

Reduced Effect of Aspirin and Clopidogrel Following Hybrid Coronary Revascularization
Clinical and Applied Thrombosis/Hemostasis2015-03-093 citations